Further of note in the patient's tumour susceptibility screen were high levels of transforming growth factor beta/TGFβ (30% over control); of the transcription factor, NFκB (35% over control) together with inhibition of IκB (a,d,e) expression; and somewhat raised epidermal growth factor receptor/EGFr (< 5%). This evidence concerns the gene NFKB1 and neoplasm.